Intervacc AB (publ) (STO:IVACC)
Sweden · Delayed Price · Currency is SEK 1.340
+0.066 (5.18%)
Jun 11, 2026, 5:29 PM CET
Intervacc AB Earnings Call Transcripts
Fiscal Year 2025
-
A novel recombinant protein vaccine for strangles in horses has shown strong safety and efficacy, with over 30,000 horses vaccinated in Europe and growing support from veterinarians. Expansion efforts target the U.S. and other major markets, with regulatory approval expected around 2027–2028.